MRC Technology and Biocartis initiate development of liquid biopsy test for breast cancer
Partnership aimed at the development of molecular diagnostic assays on Biocartis' fully automated Idylla(TM) platform
London (UK) / Mechelen (Belgium), 7 June 2017 ...




